We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$255M
Cap. Flow %
105.95%
Top 10 Hldgs %
27.78%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ROK icon
Rockwell Automation
ROK
+$8.98M
2
AIT icon
Applied Industrial Technologies
AIT
+$8.46M
3
CLH icon
Clean Harbors
CLH
+$7.13M
4
TKR icon
Timken Company
TKR
+$6.85M
5
PRIM icon
Primoris Services
PRIM
+$6.82M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 46.25%
2 Healthcare 42.59%
3 Technology 3.29%
4 Materials 2.86%
5 Financials 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMCR icon
126
Immunocore
IMCR
$1.86B
$330K 0.14%
+11,194
New +$354K
DCI icon
127
Donaldson
DCI
$10.6B
$324K 0.13%
+4,818
New +$355K
PNW icon
128
Pinnacle West Capital
PNW
$11.8B
$323K 0.13%
+3,808
New +$338K
IDXX icon
129
Idexx Laboratories
IDXX
$42.2B
$304K 0.13%
+736
New +$323K
SYK icon
130
Stryker
SYK
$116B
$287K 0.12%
+798
New +$296K
ITCI
131
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$283K 0.12%
+3,388
New +$278K
JANX icon
132
Janux Therapeutics
JANX
$1.24B
$280K 0.12%
+5,223
New +$276K
SMR icon
133
NuScale Power
SMR
$3.98B
$277K 0.12%
+15,456
New +$319K
RLAY icon
134
Relay Therapeutics
RLAY
$4.17B
$266K 0.11%
+64,655
New +$352K
JSPR icon
135
Jasper Therapeutics
JSPR
$23.6M
$266K 0.11%
+12,435
New +$259K
AGX icon
136
Argan
AGX
$5.86B
$246K 0.1%
+1,792
New +$246K
XENE icon
137
Xenon Pharmaceuticals
XENE
$5.79B
$240K 0.1%
+6,111
New +$253K
CGON icon
138
CG Oncology
CGON
$6.62B
$239K 0.1%
+8,329
New +$285K
CPRX
139
DELISTED
Catalyst Pharmaceutical
CPRX
$237K 0.1%
+11,352
New +$244K
SRPT icon
140
Sarepta Therapeutics
SRPT
$2.38B
$236K 0.1%
+1,943
New +$238K
TYL icon
141
Tyler Technologies
TYL
$14.9B
$235K 0.1%
+408
New +$247K
ARVN icon
142
Arvinas
ARVN
$614M
$227K 0.09%
+11,835
New +$288K
BDX icon
143
Becton Dickinson
BDX
$50.3B
$209K 0.09%
+922
New +$213K
SRRK icon
144
Scholar Rock
SRRK
$6.74B
$209K 0.09%
+4,836
New +$157K
ACAD icon
145
Acadia Pharmaceuticals
ACAD
$4.83B
$194K 0.08%
+10,596
New +$171K
VYGR icon
146
Voyager Therapeutics
VYGR
$216M
$84.8K 0.04%
+14,960
New +$96.4K
TALK
147
DELISTED
Talkspace
TALK
$81.4K 0.03%
+26,337
New +$80.1K
ALEC icon
148
Alector
ALEC
$275M
$27.1K 0.01%
+14,344
New +$54K
2 3 4 5
6

Similar funds

ACM
Advance Capital Management Southfield, Michigan $3.09B AUM 17.08% 1-Year Est. Return
SP
SurgoCap Partners New York $3.09B AUM 56.85% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $3.11B AUM 56.77% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

Tema ETFs's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Tema ETFs, which disclosed 148 positions worth $241M. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Rockwell Automation: 31,912 shares worth $9.12M.

By sector, the portfolio is most concentrated in Industrials at 46% of assets, followed by Healthcare and Technology.

  • Tema ETFs's largest Q4 2024 buy was Rockwell Automation: 31,912 shares worth $9.12M.
  • Tema ETFs's ten largest holdings make up 28% of its $241M portfolio in Q4 2024.
  • Tema ETFs disclosed 148 positions in Q4 2024, its first 13F filing on record.

Based on Tema ETFs's 13F filing for Q4 2024, filed 14 Feb 2025.